Pascale Fouqueray

Title: Pascale Fouqueray: Innovator in Pharmaceutical Treatments

Introduction

Pascale Fouqueray is a notable inventor based in Sins, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of genetic diseases. With a total of 3 patents to his name, his work is paving the way for innovative therapies.

Latest Patents

Fouqueray's latest patents include groundbreaking inventions. One patent focuses on the "Use of a thienopyridone derivative in the treatment of autosomal dominant polycystic kidney disease (ADPKD)." This invention relates to the use of a thienopyridone derivative, or a pharmaceutical composition comprising the same, in treating ADPKD. Another patent addresses the "Use of a thienopyridone derivative in the treatment of adrenoleukodystrophy or adrenomyeloneuropathy." This invention pertains to the use of a thienopyridone derivative, or a pharmaceutical composition comprising the same, in treating genetic neurodegenerative diseases such as adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN).

Career Highlights

Fouqueray is currently associated with Poxel, a company known for its innovative approaches in the pharmaceutical industry. His work at Poxel has allowed him to focus on developing treatments that address critical health issues.

Collaborations

Fouqueray collaborates with talented individuals in his field, including Sébastien Bolze and Sophie Hallakou-Bozec. Their combined expertise contributes to the advancement of research and development in pharmaceuticals.

Conclusion

Pascale Fouqueray is a distinguished inventor whose work is making a significant impact in the treatment of genetic diseases. His innovative patents and collaborations highlight his commitment to advancing medical science.